Path:
Home >
MISC >
Page351 > WS 322.1-2010
| Std ID | Version | USD | Buy | Deliver [PDF] in | Title (Description) |
| WS 322.1-2010 | English | 399 |
Add to Cart
|
3 days [Need to translate]
|
Technical standards of prenatal screening and diagnosis for fetal common chromosomal abnormalities and open neural tube defects. Part 1: Maternal serum prenatal screening in second trimester
|
Click to Preview a similar PDF
Basic data
| Standard ID | WS 322.1-2010 (WS322.1-2010) |
| Description (Translated English) | Technical standards of prenatal screening and diagnosis for fetal common chromosomal abnormalities and open neural tube defects. Part 1: Maternal serum prenatal screening in second trimester |
| Sector / Industry | Health Industry Standard |
| Classification of Chinese Standard | C59 |
| Classification of International Standard | 11.020 |
| Word Count Estimation | 10,122 |
| Date of Issue | 2010-06-08 |
| Date of Implementation | 2010-12-31 |
| Quoted Standard | WS/T 247; WS/T 250 |
| Regulation (derived from) | ?Health-Communication (2010) 17; Industry Standard Filing Announcement 2010 No.7 (Total No.127) |
| Issuing agency(ies) | National Health and Family Planning Commission of the People's Republic of China |
| Summary | This standard specifies the parent trimester prenatal serologic screening procedures, informed consent, screening data and specimen collection, laboratory testing, informed of the outcome and treatment for high-risk pregnant women and followed up requirements. This section applies to the time of birth below the age of 35 pregnant women in the second trimester of fetal common chromosomal abnormalities (Down's syndrome and 18-trisomy) serum and open neural tube defects school prenatal screening. |
WS 322.1-2010: Technical standards of prenatal screening and diagnosis for fetal common chromosomal abnormalities and open neural tube defects. Part 1: Maternal serum prenatal screening in second trimester
---This is a DRAFT version for illustration, not a final translation. Full copy of true-PDF in English version (including equations, symbols, images, flow-chart, tables, and figures etc.) will be manually/carefully translated upon your order.
Technical standards of prenatal screening and diagnosis for fetal common chromosomal abnormalities and open neural tube defects. Part 1. Maternal serum prenatal screening in second trimester
ICS 11.020
C59
Record number. 29140-2010
People's Republic of China health industry standards
Fetal common chromosomal abnormalities and openness
Prenatal screening and diagnostic criteria for neural tube defects
Part 1. Prenatal screening of maternal serology in pregnancy
Technical standards of prenatalscreeninganddiagnosisfor
Part 1. Maternalserumprenatalscreeninginsecondtrimester
2010-06-08 released
2010-12-31 implementation
Ministry of Health of People's Republic of China released
Foreword
WS 322 "Prenatal screening and diagnostic techniques for common chromosomal abnormalities in the fetus and open neural tube defects" is now published as follows
section.
--- Part 1. prenatal screening of maternal serology in the second trimester;
--- Part 2. Fetal common chromosomal abnormalities cytogenetic prenatal diagnostic criteria.
This part is the first part of WS 322.
This part of the Appendix A is informative, Appendix B is a normative appendix.
This section proposed by the Ministry of Health Medical Services Standards Committee.
This part of the People's Republic of China Ministry of Health approval.
This section mainly drafted by. Chinese Academy of Medical Sciences Beijing Union Medical College Hospital, Yunnan First People's Hospital, Sichuan University, West China Second Medical
Hospital, Zhejiang University School of Medicine Obstetrics and Gynecology Hospital.
The main drafters of this section. Bian Xuming, Zhu Baosheng, Liu Juntao, Wang and Lv Shiming, Ma Liangkun, Jiang Yu Lin, Qi Qing Wei, Xia Jiahui,
Sun nirvana.
Fetal common chromosomal abnormalities and openness
Prenatal screening and diagnostic criteria for neural tube defects
Part 1. Prenatal screening of maternal serology in pregnancy
1 Scope
WS 322 provisions of this part of the maternal serological prenatal screening program, informed consent, screening materials and specimens collected
Set, laboratory tests, notification of results and treatment and follow-up of high-risk pregnant women.
This section applies to childbirth at the age of 35 pregnant women in the second trimester of pregnancy common chromosomal abnormalities (Down's syndrome and
18-trisomy syndrome) and serological prenatal screening of open neural tube defects.
2 Normative references
The following documents for the application of this document is essential. For dated references, only the dated version applies to this article
Pieces. For undated references, the latest edition (including all amendments) applies to this document.
WS/T 247 alpha fetoprotein detection of prenatal monitoring and open guidelines for the diagnosis of neural tube defects
WS/T 250 clinical laboratory quality assurance requirements
3 Terms and definitions
The following terms and definitions apply to this document.
3.1
Common fetal chromosomal abnormalities commonchromosomeabnormalities
Chromosomal disorders are the most common genetic disorder that causes birth defects in newborns. About 400 kinds of chromosomal diseases, of which common
There are more than 60 species, the major chromosomal abnormalities are 21-trisomy (Down's Syndrome), 18-trisomy and 13-trisomy and sex-stained
Body abnormalities, followed by chromosomal abnormalities.
3.2
Open neural tube defects in openneuraltubedefects
4 weeks pregnant embryo neural tube is not closed, according to the location of the defect and the clinical manifestations of different severity of open neural tube defects
Including anencephaly and open spina bifida, the former is fatal and can lead to miscarriage, stillbirth or stillbirth, the latter can be paralyzed and incontinent
Other symptoms.
3.3
During pregnancy, thesecondtrimester
Pregnancy 13 weeks ~ 20 6 weeks, the screening time during pregnancy usually refers to 15 weeks pregnant to 20 6 weeks.
3.4
Prenatal screening prenatalscreening
Through the simple, economical and less traumatic testing methods, some fetuses with congenital defects and genetic diseases are found in the pregnant women group
High-risk pregnant women, in order to further confirm the diagnosis.
...
